Zymergen Inc Equity-NMS: ZY

Basic Materials

Specialty Chemicals

Buy/Sell an entire stock
or a fraction.

Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly

Loading, Please wait...

Error in Fetching Data, Please retry later.

No data available.

Previous close :

$2.39

5Y :

-94.09%

What is the share price of Zymergen Inc today?

Zymergen Inc (ZY) share price as of March 14, 2025, is $2.43. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Zymergen Inc?

Yes, Indian Investors can invest in the Zymergen Inc (ZY) Share by opening an international trading account with Angel One.

How can I purchase Zymergen Inc shares in India?

Purchasing Zymergen Inc (ZY) share from India can be done by:

Directly: By opening an international trading account with Angel One. The process would include KYC verification.
The account activation takes a few minutes to a few hours, after which you can start buying Zymergen Inc (ZY) by making deposits in US dollars.
Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Zymergen Inc?

Yes, you can purchase fractional shares of Zymergen Inc (ZY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Zymergen Inc?

The market capitalization of Zymergen Inc on March 14, 2025, is $0.

In which sector Zymergen Inc belongs?

Zymergen Inc operates in the Basic Materials sector, specifically in the Specialty Chemicals industry.

What documents are required to invest in Zymergen Inc stocks?

In order to invest in Zymergen Inc (ZY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

Zymergen Inc. integrates computational and manufacturing technologies to design, develop, and commercialize bio-based products in a range of industries. Its platform consists of three key capabilities: its collection of accessible biomolecules; its software and data science technology, and its data-driven microbe optimization processes. Its businesses include advanced materials, which seeks to employ bio-advantaged molecules or microbes to develop and deliver products and is focused on four markets: agriculture, water repellency, advanced polymers, and healthcare; drug discovery business leverages its differentiated access to natural products as a source of diverse chemical matter provided by its unified metagenomics database, and automation business, which offers automation technology to organizations involved in lab operations. Its software and data science platform informs, guides, and records its experiments forming the infrastructure for the learning cycle.